Used in immunosuppressive therapy, particularly in organ transplantation to prevent rejection. Shows potential for enhanced selectivity and prolonged activity compared to tacrolimus, making it a candidate for improved therapeutic regimens in autoimmune diseases and transplant medicine. Investigated for topical formulations targeting inflammatory skin conditions due to increased tissue penetration and reduced systemic exposure. Also explored in drug delivery systems aiming to optimize bioavailability and minimize side effects.